Ultinad® NMN

The Gold Standard in NAD⁺ Science

Compliance Readiness Peace of mind for global regulatory approval

• Pharma GMP compliant 21 CFR 210/211
• Complete GRAS Documentation: Full toxicology study, tolerance study, expert panel review
• Audit-Ready: full traceability and documentation

Manufacturing Excellence Reliable supply chain, premium quality, and confidence in long-term product stability.

• Patented Enzymatic Production Process: World’s first ton-scale NMN line
• Pharma GMP Standards: Pharmaceutical-grade protocols ensure highest safety and consistency
• Large-Scale Capacity: 15 MT/month, $50M+ infrastructure and R&D investment
• 5-Year Stability Data: Proven shelf life and reliability in real-market conditions
• Pharma-Grade Purity (99.9%): No α-isomers, no solvent residues

Backed by Science Scientifically proven efficacy, trusted by global leaders, and safe for the strictest applications including infant nutrition.

• IONTOX Mode of Action Study: Demonstrated superior bioavailability, absorption, and NAD⁺ conversion vs NR
• Human Milk Study (Nutrients, 2024): NMN identified as major NAD⁺ precursor correlated with infant neurodevelopment. Total of 150 mother-child pairs.
• Randomized Controlled Trial (GeroScience, 2024): 250 mg/day NMN for 12 weeks: Increased blood NAD⁺levels, Improved walking speed, Enhanced sleep quality, No serious adverse events
• Exclusive Meiji Partnership: Supplier to Japan’s #1 dairy brand, admitted into infant milk powder system

Ultinad® NMN combines compliance readiness, manufacturing excellence, and scientific validation to deliver the Gold Standard in NMN—trusted by premium brands worldwide for purity, safety, and proven performance.